This compound is primarily utilized in the pharmaceutical industry as an intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its structure, featuring difluoro and methyl groups, makes it valuable in the development of chiral drugs, particularly those targeting central nervous system disorders. It is also employed in organic synthesis for creating complex molecules with specific stereochemistry, aiding in the production of compounds with enhanced biological activity and selectivity. Additionally, it finds use in research settings for studying enzyme interactions and receptor binding due to its unique stereochemical properties.